ANNX
Price
$4.20
Change
+$0.09 (+2.19%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
447.69M
61 days until earnings call
DNTH
Price
$20.01
Change
+$0.80 (+4.16%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
591.94M
Ad is loading...

ANNX vs DNTH

Header iconANNX vs DNTH Comparison
Open Charts ANNX vs DNTHBanner chart's image
Annexon
Price$4.20
Change+$0.09 (+2.19%)
Volume$13.97K
Capitalization447.69M
Dianthus Therapeutics
Price$20.01
Change+$0.80 (+4.16%)
Volume$2.37K
Capitalization591.94M
ANNX vs DNTH Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. DNTH commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Hold and DNTH is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (ANNX: $4.11 vs. DNTH: $19.21)
Brand notoriety: ANNX and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 278% vs. DNTH: 167%
Market capitalization -- ANNX: $447.69M vs. DNTH: $591.94M
ANNX [@Biotechnology] is valued at $447.69M. DNTH’s [@Biotechnology] market capitalization is $591.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileDNTH’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • DNTH’s FA Score: 0 green, 5 red.
According to our system of comparison, ANNX is a better buy in the long-term than DNTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 3 TA indicator(s) are bullish while DNTH’s TA Score has 2 bullish TA indicator(s).

  • ANNX’s TA Score: 3 bullish, 5 bearish.
  • DNTH’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ANNX is a better buy in the short-term than DNTH.

Price Growth

ANNX (@Biotechnology) experienced а -15.08% price change this week, while DNTH (@Biotechnology) price change was -24.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

ANNX is expected to report earnings on May 19, 2025.

DNTH is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($592M) has a higher market cap than ANNX($448M). DNTH YTD gains are higher at: -11.881 vs. ANNX (-19.883). DNTH has higher annual earnings (EBITDA): -82.47M vs. ANNX (-129.45M). ANNX has more cash in the bank: 340M vs. DNTH (281M). DNTH has less debt than ANNX: DNTH (311K) vs ANNX (29.6M). DNTH has higher revenues than ANNX: DNTH (5.37M) vs ANNX (0).
ANNXDNTHANNX / DNTH
Capitalization448M592M76%
EBITDA-129.45M-82.47M157%
Gain YTD-19.883-11.881167%
P/E RatioN/A2.77-
Revenue05.37M-
Total Cash340M281M121%
Total Debt29.6M311K9,518%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXDNTH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
84%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with DNTH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then DNTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-3.07%
DNTH - ANNX
40%
Loosely correlated
-4.48%
FULC - ANNX
37%
Loosely correlated
-2.93%
ERAS - ANNX
37%
Loosely correlated
-3.12%
TCRX - ANNX
37%
Loosely correlated
-7.17%
IMNM - ANNX
36%
Loosely correlated
-2.47%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-4.48%
IMNM - DNTH
42%
Loosely correlated
-2.47%
ANNX - DNTH
39%
Loosely correlated
-3.07%
SLDB - DNTH
39%
Loosely correlated
+3.50%
TRDA - DNTH
38%
Loosely correlated
+2.37%
SYRE - DNTH
37%
Loosely correlated
-5.12%
More